Table 3.
Odds ratios of calcified coronary plaque per one standard deviation increment in fat measures in 398 MESA participants, 2002–2005
| Odds ratio* (95% confidence interval) |
|||
|---|---|---|---|
| Model 1† | Model 2‡ | Model 3§ | |
| Body mass index ∥, 5.2 kg/m2 | 1.30 (1.03, 1.65) | 1.29 (1.03, 1.61) | 1.21 (0.93, 1.59) |
| Waist circumference ∥, 14.5 cm | 1.30 (1.03, 1.64) | 1.30 (1.03, 1.65) | 1.19 (0.92, 1.54) |
| Pericardial fat ∥, 43.4 cm3 | 1.41 (1.06, 1.88) | 1.38 (1.04, 1.84) | 1.39 (0.99, 1.95) |
| Abdominal visceral fat ∥, 104 mm3 | 1.35 (1.04, 1.76) | 1.35 (1.03, 1.76) | 1.29 (0.93, 1.78) |
| Liver attenuation ∥, 10.9 HU | 0.79 (0.63, 1.01) | 0.80 (0.63, 1.02) | 0.85 (0.64, 1.11) |
| Intermuscular fat ∥, 12.6 mm3 | 1.15 (0.90, 1.48) | 1.15 (0.89, 1.49) | 1.13 (0.87, 1.47) |
| Abdominal subcutaneous fat ∥, 220 mm3 | 1.24 (0.97, 1.58) | 1.23 (0.96, 1.57) | 1.12 (0.87, 1.48) |
| Non-subcutaneous fat index ∥, 2.9 | 1.43 (1.10, 1.86) | 1.41 (1.08, 1.84) | 1.40 (1.01, 1.93) |
*
Logistic regression analysis
†
Including age, gender, ethnicity, height and one fat measure
‡
Including age, gender, ethnicity, smoking status, alcohol drinking status, height and one fat measure
§
Including age, gender, ethnicity, smoking status, alcohol drinking status, systolic blood pressure, anti-hypertensive medication, HDL, triglycerides, cholesterol-lowering medication, diabetes, height and one fat measure
∥
Per standard deviation